Alaffia Health Ranked Top 50 Digital Health Company by CB Insights

12.06.2024

Congratulations to Alaffia Health for being recognized in CB Insights’ Digital Health 50 — an annual list of the most promising digital health startups in the world, selected based on a combination of data signals and proprietary scoring.

For health system CIOs, digital health investors, and life sciences executives, this list spotlights companies to explore for technology adoption, investment opportunities, and strategic partnerships as healthcare shifts toward AI-driven infrastructure, advanced diagnostics, and specialized care platforms.

Four key themes emerged from this year’s cohort…[click here to continue reading]

Announcing Our Continued Investment In Alaffia’s $55M Series B

Alaffia is proving what happens when AI is built with deep vertical context and clinical-grade rigor: faster decisions, higher accuracy, and real economic impact for health plans. We’re excited to back the team as they expand from claims review into the agent-powered operating layer for health plan operations.
Health Companions: The Coming Consumer OS & Agentic Layer for Healthcare

The ongoing shift from passive Systems of Record to active Systems of Agency will be profound. This analysis outlines the companies building the patient-first stack, and the traits of the inevitable winners within Consumer Health.
Ro CEO Zach Reitano talks launch of Wegovy’s GLP-1 pill

Ro Co-Founder and CEO Zach Reitano joins 'Fast Money' to talk the launch of Wegovy's oral GLP-1 offering, demand for the pill, and its partnership with Novo Nordisk to distribute the medication.

Alaffia Health Ranked Top 50 Digital Health Company by CB Insights

Social Sharing

12.06.2024

You may also like

Announcing Our Continued Investment In Alaffia’s $55M Series B

Health Companions: The Coming Consumer OS & Agentic Layer for Healthcare

Ro CEO Zach Reitano talks launch of Wegovy’s GLP-1 pill